Ming-yuan Chen
Clinical trials sponsored by Ming-yuan Chen, explained in plain language.
-
Cancer trial aims to cut radiation damage while boosting immune power
Disease control Recruiting nowThis study is for people newly diagnosed with nasopharyngeal cancer that has spread. It compares two radiation approaches given after chemotherapy and immunotherapy. One approach targets a smaller area to try to reduce side effects and possibly help the immune system work better.…
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Could less radiation mean fewer side effects for throat cancer patients?
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal (upper throat) cancer who have already responded well to initial drug treatments. It aims to see if using a lower dose of radiation therapy works as well as the standard dose at keeping the cancer from returning, while hopeful…
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can less radiation be just as effective for throat cancer?
Disease control Recruiting nowThis study is for people with a specific intermediate-stage nasopharyngeal (upper throat) cancer that has responded well to initial drug treatment. It compares a lower dose of radiation to the standard dose, both given alongside immunotherapy. The goal is to see if the lower dose…
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New hope for Tough-to-Treat head & neck cancer: trial tests four promising drug combos
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal cancer (a type of head and neck cancer) that has come back or spread and has stopped responding to standard treatments, including immunotherapy. It aims to find out which of four different drug combinations is safest and most …
Phase: PHASE2 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC